| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/07/2004 | EP1404827A2 Lipolytic enzyme genes |
| 04/07/2004 | EP1404826A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 04/07/2004 | EP1404825A2 A WALK-THROUGH TECHNIQUE FOR i IN VITRO /i RECOMBINATION OF POLYNUCLEOTIDE SEQUENCES |
| 04/07/2004 | EP1404821A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404819A2 Synthetic viruses and uses thereof |
| 04/07/2004 | EP1404818A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP1404814A2 Nuclear fertility restorer genes and methods of use in plants |
| 04/07/2004 | EP1404813A2 Methods of culturing animal cells and polypeptide production in animal cells |
| 04/07/2004 | EP1404812A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 04/07/2004 | EP1404811A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/07/2004 | EP1404809A2 Improved skin substitutes and uses thereof |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof |
| 04/07/2004 | EP1404715A2 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeutic use |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404713A1 Novel keratinocyte growth factor-2 analogue in hair follicle |
| 04/07/2004 | EP1404711A2 Mutated photoproteins and their uses |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404709A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404708A2 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1 |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404705A1 Compositions and methods of using hiv vpr |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404699A2 Antisense modulation of src-c expression |
| 04/07/2004 | EP1404698A2 Antisense modulation of superoxide dismutase 1, soluble expression |
| 04/07/2004 | EP1404631A1 Method of functionalising solid supports |
| 04/07/2004 | EP1404374A1 Slc2as as modifiers of the p53 pathway and methods of use |
| 04/07/2004 | EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404307A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 04/07/2004 | EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1363931A4 Methods to generate and identify monoclonal antibodies to a large number of human antigens |
| 04/07/2004 | EP1124843B1 Low allergenic protein variants |
| 04/07/2004 | EP1100900B1 Xiap ires and uses thereof |
| 04/07/2004 | EP1066404A4 Methods for producing libraries of expressible gene sequences |
| 04/07/2004 | EP1015622B1 Practical in vitro sialylation of recombinant glycoproteins |
| 04/07/2004 | EP1007728A4 Nucleic acid amplification method: hybridization signal amplification method (hsam) |
| 04/07/2004 | EP0979277B1 Novel human tumour suppressor gene |
| 04/07/2004 | EP0889905B1 Cytokine antagonists and agonists |
| 04/07/2004 | EP0854914B1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0726955B1 Chimeric proteins comprising borrelia polypeptides: uses therefor |
| 04/07/2004 | EP0587791B1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
| 04/07/2004 | EP0559884B2 Viral recombinant vectors for expression in muscle cells |
| 04/07/2004 | CN1488002A Method of determining epidermal growth factor receptor and HER2-Neu gene expression and correlation of levels thereof with survival rates |
| 04/07/2004 | CN1488000A Method for purification of soluble SSAO |
| 04/07/2004 | CN1487999A Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| 04/07/2004 | CN1487998A Gene encoding acetolactic acid sy nthase gene |
| 04/07/2004 | CN1487997A Gene HD3A inducing flowering of plant and utilization thereof |
| 04/07/2004 | CN1487996A Transgenic transchromosomal rodents for making human antibodies |
| 04/07/2004 | CN1487995A Low-Lipoxygenase 1 barley |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487868A Pressure vessel systems and methods for dispensing liquid chemical compositions |
| 04/07/2004 | CN1487841A Lentiviral vector-mediated gene transfer and uses thereof |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487093A Method of dissolving nucleic acid in water insoluble medium and its application |
| 04/07/2004 | CN1487091A Identification method of PCR-restriction map for fritillary bulb and similar medicine material |
| 04/07/2004 | CN1487086A Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor |
| 04/07/2004 | CN1487085A Conotoxin MVÔàí A and Trx fusion protein and its expression and application |
| 04/07/2004 | CN1487084A Rice root system phosphorus starvation induction specific expression promoter and its plant culture method |
| 04/07/2004 | CN1487083A Rockfish insulin-like growth factor Ôàí gene, carrier and recombinant strain containing the gene and their application |
| 04/07/2004 | CN1487082A Depilation related gene and its application |
| 04/07/2004 | CN1487081A Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 04/07/2004 | CN1487079A Fermentation production process for phosphoglyceric acid family amino-acid and amino-acid derivative |
| 04/07/2004 | CN1486990A Humanized gene engineering antibody resisting hepatitis E virus |
| 04/07/2004 | CN1145028C Method for gold deposition |
| 04/07/2004 | CN1144876C Process for producing cis-3-hydroxy-L-proline |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |
| 04/07/2004 | CN1144874C Production of enzymatically active recombinant carboxypeptidase B |
| 04/07/2004 | CN1144817C Novel human 'beta' 2 integrin 'alpha' sub unit |
| 04/07/2004 | CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 04/07/2004 | CN1144517C Asymmetrical cytomixis method for leaf-unrolling Chinese cabbage and the regenerated plant obtained thereby |
| 04/06/2004 | US6717035 Insect resistance; genome comprising nucleic acid sequence 4 |
| 04/06/2004 | US6717034 Altering transcription factor levels |
| 04/06/2004 | US6717033 Transforming plant cells to alter the metabolic state |
| 04/06/2004 | US6717032 Transgenic mice containing DEZ orphan receptor gene disruptions |
| 04/06/2004 | US6717031 Method for selecting a transgenic mouse model of alzheimer's disease |
| 04/06/2004 | US6717030 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 04/06/2004 | US6716975 Antisense modulation of EDG1 expression |
| 04/06/2004 | US6716974 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 04/06/2004 | US6716973 Nucleotide sequences coding polypeptide for use in the generation preferential biopolymers |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |
| 04/06/2004 | US6716967 Purified monoclonal antibody or binding portion thereof that specifically binds to a rupestris stem pitting associated virus coat protein or coat protein polypeptide |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716960 Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use |
| 04/06/2004 | US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716631 Evolution of whole cells and organisms by recursive sequence recombination |
| 04/06/2004 | US6716629 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 04/06/2004 | US6716627 Mucin 1, transmembrane may help to frustrate infection in the mammary gland (mastitis) and possibly in other sites in the body (such as bladder and kidney infections) by competitively inhibiting the binding of microorganisms |
| 04/06/2004 | US6716624 GSK3 polypeptides |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716622 Tissue-specific self-inactivating gene therapy vector |
| 04/06/2004 | US6716621 Isolated DNA or gene responsible for Parkinson's disease |
| 04/06/2004 | US6716613 Metalloprotease having aggrecanase activity |